{"id":850,"date":"2021-02-19T11:04:16","date_gmt":"2021-02-19T11:04:16","guid":{"rendered":"https:\/\/nclinnovations.org\/covid19monitor\/?p=850"},"modified":"2021-02-19T11:04:16","modified_gmt":"2021-02-19T11:04:16","slug":"17-feb-2021-nitazoxanide-ivermectin-ribavirin-plus-zinc-effectively-clear-the-sars-cov2-from-nasopharynx","status":"publish","type":"post","link":"https:\/\/nclinnovations.org\/covid19monitor\/17-feb-2021-nitazoxanide-ivermectin-ribavirin-plus-zinc-effectively-clear-the-sars-cov2-from-nasopharynx\/","title":{"rendered":"(17 Feb 2021) Nitazoxanide, Ivermectin, Ribavirin- plus Zinc effectively clear the SARS-COV2 from nasopharynx"},"content":{"rendered":"<div class=\"boldgrid-section\">\n<div class=\"container\">\n<div class=\"row\">\n<div class=\"col-md-12 col-xs-12 col-sm-12\">\n<p>Effect of a combination of Nitazoxanide, Ribavirin and Ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID-19<\/p>\n<p>https:\/\/doi.org\/10.1002\/jmv.26880<\/p>\n<p class=\"\">NCT04392427- This non-randomized controlled trial included 62 patients on triple combination treatment versus 51 age- and sex-matched patients on routine supportive treatment all of them confirmed case by positive RT-PCR of nasopharyngeal swab. Trial results showed that the clearance rates were 0% and 58.1% at 7th day and 13.7% and 73.1% at the 15th day in supportive treatment and combined antiviral groups, respectively. The cumulative clearance rates at 15th day are 13.7 and 88.7% in supportive treatment and combined antiviral groups, respectively. This trial concluded that combined use of Nitazoxanide, Ribavirin, and Ivermectin plus zinc supplement effectively clear the SARS-COV2 from nasopharynx in shorter time than the symptomatic therapy.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Effect of a combination of Nitazoxanide, Ribavirin and Ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID-19 https:\/\/doi.org\/10.1002\/jmv.26880 NCT04392427- This non-randomized controlled trial included 62 patients on triple combination treatment versus 51 age- and sex-matched patients on&hellip; <span class=\"read-more-span\"><a href=\"https:\/\/nclinnovations.org\/covid19monitor\/17-feb-2021-nitazoxanide-ivermectin-ribavirin-plus-zinc-effectively-clear-the-sars-cov2-from-nasopharynx\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;(17 Feb 2021) Nitazoxanide, Ivermectin, Ribavirin- plus Zinc effectively clear the SARS-COV2 from nasopharynx&#8221;<\/span> <span class=\"genericon genericon-next\"><\/span><\/a><\/span><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"bgseo_title":"","bgseo_description":"","bgseo_robots_index":"index","bgseo_robots_follow":"follow"},"categories":[6,4,16,85],"tags":[38,86],"_links":{"self":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/850"}],"collection":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/comments?post=850"}],"version-history":[{"count":1,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/850\/revisions"}],"predecessor-version":[{"id":851,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/posts\/850\/revisions\/851"}],"wp:attachment":[{"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/media?parent=850"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/categories?post=850"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nclinnovations.org\/covid19monitor\/wp-json\/wp\/v2\/tags?post=850"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}